Deubiquitylating Enzymes in Cancer and Immunity

Jiang Ren1, Peng Yu2, Sijia Liu3,4

  • 1The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518033, P. R. China.

Insights

Deubiquitylating enzymes (DUBs) regulate cellular processes by removing ubiquitin. Their dysregulation is linked to cancer and immune disorders, highlighting their complex roles.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Deubiquitylating enzymes (DUBs) are crucial for maintaining cellular homeostasis by removing ubiquitin.
  • DUBs exhibit specificity in cleaving ubiquitin chains and can function independently of their catalytic activity.
  • Dysregulation of DUBs contributes to diseases, particularly cancer and immune disorders.

Purpose of the Study:

  • To review the dual roles of DUBs in cancer development and progression.
  • To summarize the involvement of DUBs in various immune system functions and disorders.
  • To discuss the potential and challenges of developing DUB inhibitors for clinical applications.

Main Methods:

  • Literature review of DUBs' functions in cancer.
  • Analysis of DUBs' roles in innate and adaptive immunity.
  • Examination of clinical development prospects for DUB inhibitors.

Main Results:

  • DUBs play Janus-faced roles in cancer, influencing proteasomal degradation, DNA repair, apoptosis, and metastasis.
  • DUBs are implicated in innate immune receptor signaling, inflammation, and autoimmune diseases.
  • The clinical development of DUB inhibitors presents both opportunities and challenges.

Conclusions:

  • DUBs are critical regulators with multifaceted roles in cancer and immunity.
  • Understanding DUBs' complex functions is essential for developing targeted therapies.
  • Further research into DUB inhibitors holds promise for treating cancer and immune-related diseases.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
857
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K